Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.

 

Category: Cardiovascular

Is there any consensus about prophylactic anticoagulation in patients without known venous thromboembolism?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on January 13, 2021.

   Estimated Time: 04:48 Anticoagulation, Coronavirus, COVID-19

Early Respiratory Outcomes Following Cardiac Surgery in Patients With COVID‐19

This resource details early respiratory outcomes following cardiac surgery in patients with COVID‐19. This is a community developed COVID-19 microlearning resource.

   Estimated Time: 18:22 Clinical presentations, Coronavirus, COVID-19

When you are called to accept a patient in an ECMO center, what are your considerations for transfer? What information would you like to know from the referring team and what interventions should be performed?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on December 9, 2020.

   Estimated Time: 05:14 Coronavirus, COVID-19, ECMO

How do we prevent VTEs and how do we survey for them? Should patients receive standard prophylaxis? Should all ventilated patients receive full-dose anticoagulation? What are your practices and how have you approached this at your center?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on December 9, 2020.

   Estimated Time: 06:50 Anticoagulation, Coronavirus, COVID-19

Experience With Cardiology-Oriented Outcomes in Critically Ill Patients With Coronavirus Disease 2019

From Critical Care Explorations The authors share data and recommendations from a multidisciplinary team to highlight our institution’s clinical experiences and guidelines for managing cardiovascular complications of coronavirus disease 2019.

   Estimated Time: 23:06 Coronavirus, COVID-19

Letter to the Editor: Caution Is Needed When Reporting or Pooling the Prevalence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients

From Critical Care Medicine In this Letter to the Editor, the author discusses the difficulties to ascertain in ICU settings the exact VTE incidence, incidence rate, or prevalence due to various reasons, including the absence of uniform screening at ICU admission to exclu...

   Estimated Time: 3:42 Cardiovascular, Coronavirus, COVID-19

Is Cardiopulmonary Resuscitation Futile in Coronavirus Disease 2019 Patients Experiencing In-Hospital Cardiac Arrest?

From Critical Care Medicine The authors describe the characteristics and outcomes of in-hospital cardiac arrest in coronavirus disease 2019 patients in rural Southwest Georgia.

   Estimated Time: 19:45 min Cardiovascular, Coronavirus, COVID-19

What is double anticoagulation prophylaxis?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on October 14, 2020.

   Estimated Time: 01:12 min Anticoagulation, Coronavirus, COVID-19

Are you using typical DVT prophylaxis or something more, such as therapeutic anticoagulation?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on October 14, 2020.

   Estimated Time: 02:08 min Anticoagulation, Coronavirus, COVID-19

What is double anticoagulation prophylaxis?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on October 14, 2020.

   Estimated Time: 01:12 min Anticoagulation, Coronavirus, COVID-19, Therapies

Are you using typical DVT prophylaxis or something more, such as therapeutic anticoagulation?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on October 14, 2020.

   Estimated Time: 02:08 min Anticoagulation, Coronavirus, COVID-19, DVT

Have you become more aggressive in placing arterial lines in these patients when you might have only monitored pulse oximetry in the past?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on September 9, 2020.

   Estimated Time: 00:39 min Cardiovascular, Coronavirus, COVID-19

Letter to the Editor: Prevalence and Clinical Correlates of Echo-Estimated Right and Left Heart Filling Pressures in Hospitalized Patients With Coronavirus Disease 2019

From Critical Care Explorations In this Letter to the Editor, the authors discuss their study in which they hypothesized that a significant proportion of coronavirus disease 2019 patients has evidence of pulmonary hypertension associated with elevated left heart filling pressu...

   Estimated Time: 09:59 min Cardiovascular, Coronavirus, COVID-19, Diagnosis and Testing

SCCM Pod-423 Coagulopathy in COVID-19 Patients

COVID-19 is associated with a high prevalence of coagulopathy and venous thromboembolism. Host B. Kyle Enfield, MD, FCCM, talks with Jerrold H. Levy, MD, FAHA, FCCM, about what clinicians need to know about this serious problem and how it impacts care delivery (Iba et al. Crit...

   Estimated Time: 37:30 min Cardiovascular, Coronavirus, COVID-19, Disaster Preparedness

Higher Intensity Thromboprophylaxis Regimens and Pulmonary Embolism in Critically Ill Coronavirus Disease 2019 Patients

From Critical Care Medicine. In this study from Belgium, the authors assessed the role of thromboprophylaxis regimens on the occurrence of pulmonary embolism in coronavirus disease 2019 patients.

   Estimated Time: 12:01 min Anticoagulation, Coronavirus, COVID-19

Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation

From Critical Care Medicine. Deep venous thrombosis is very common in critically ill patients with coronavirus disease 2019, so the authors describe the prevalence of venous thromboembolism in critically ill patients receiving different regimens of prophylactic anticoagulation.

   Estimated Time: 10:28 min Anticoagulation, Coronavirus, COVID-19

Letter to the Editor: Barrier Techniques to Reduce Aerosolization During Cardiopulmonary Resuscitation

From Critical Care Explorations. The authors developed additional modifications to the suggested guidelines to further protect providers from unnecessary aerosolization; it illustrates a sample protocol for provider safety during advanced cardiovascular life support in the cor...

   Estimated Time: 04:55 min Coronavirus, COVID-19, Infection Control

Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans

From Critical Care Medicine. The authors report a 100% occurrence of venous thromboembolism in critically ill patients supported by venovenous extracorporeal membrane oxygenation for severe acute respiratory syndrome coronavirus 2-related acute respiratory distress syndrome us...

   Estimated Time: 15:03 min Coronavirus, COVID-19, ECMO, Supportive Care

Letter to the Editor: Optimizing the Risk-Benefit Balance of Thromboprophylaxis in Critically Ill Patients With Coronavirus Disease 2019

From Critical Care Medicine. This Letter to the Editor is in response to an article by Iba et al. (Coagulopathy of Coronavirus Disease 2019) and discusses dosing recommendations of low molecular weight heparin.

   Estimated Time: 02:00 min Coronavirus, COVID-19, Therapies

Letter to the Editor: Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients

From Critical Care Explorations. In this Letter to the Editor, the authors report their adapted thromboprophylaxis practice of low-molecular-weight heparin administration in coronavirus disease 2019 ICU patients.

   Estimated Time: 07:04 min Coronavirus, COVID-19, Therapies